Novadaq Technologies Inc. (NDQ) Lowered to Neutral at Wedbush

Wedbush downgraded shares of Novadaq Technologies Inc. (TSE:NDQ) (NASDAQ:NVDQ) from an outperform rating to a neutral rating in a research report released on Monday morning.

A number of other equities analysts have also recently commented on NDQ. Scotiabank reiterated an outperform rating and issued a C$13.25 target price on shares of Novadaq Technologies in a report on Wednesday, March 1st. Royal Bank Of Canada dropped their target price on Novadaq Technologies to C$16.00 and set an outperform rating for the company in a report on Wednesday, March 1st. William Blair reiterated a market perform rating on shares of Novadaq Technologies in a report on Wednesday, May 3rd. Finally, Craig Hallum reiterated a buy rating on shares of Novadaq Technologies in a report on Thursday, May 4th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Novadaq Technologies has a consensus rating of Buy and a consensus price target of C$15.42.

Shares of Novadaq Technologies (TSE NDQ) traded up 0.78% during mid-day trading on Monday, reaching $15.60. The company’s stock had a trading volume of 27,856 shares. Novadaq Technologies has a 52-week low of $7.81 and a 52-week high of $16.42. The company’s market cap is $901.71 million. The company has a 50-day moving average price of $9.72 and a 200 day moving average price of $9.63.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/2655421/novadaq-technologies-inc-ndq-lowered-to-neutral-at-wedbush.html.

About Novadaq Technologies

NOVADAQ Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “TSX:NDQ”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Blue Apron Filed Thursday for Public Offering
Blue Apron Filed Thursday for Public Offering
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Large Auto Lender Checked Just 8% of Incomes for Applicants
Large Auto Lender Checked Just 8% of Incomes for Applicants


Leave a Reply

© 2006-2017 Ticker Report. Google+.